SEARCH RESULTS

225373 RESULTS

VY-AADC

THERAPEUTICS Voyager Therapeutics DNA-based Other Neurotransmitters In 2013, Voyager started enrolling 15 people who had had PD for at least five years and were on levodopa therapy into an open-label trial. It compared three ascending doses of VY-AADC, delivered once ...

Shyuan Steyn


The University of Queensland
Brisbane, Australia

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE